| As technology improves, the medical device industry | | | | the medical device market. |
| keeps on growing. New products are developed and | | | | Pharmaceutical training comes in several forms |
| old ones are modified. We now have devices as | | | | however the two most common are in-house training |
| simple as the triangle bandage and as complex as a | | | | sessions and external training conferences. |
| prosthetic knee joint. People come into contact with | | | | The first is where a pharmaceutical consultant will |
| medical devices on a daily basis, and modern medicine | | | | visit the production premises and directly advise |
| would not be at the level it is today had these | | | | management and staff members on the techniques |
| devices not been developed. | | | | used, computer systems and storage facilities. They |
| Pharmaceutical training needs to be given to | | | | can also help companies with areas of development |
| members of staff at hospitals, doctors surgeries, | | | | such as Clinical trials, research and laboratory |
| public places, even private places of work, wherever | | | | structures. |
| there is a first aid officer practically. For the | | | | The latter option is where employees will be sent out |
| manufacturers of these medical devices, they use | | | | to training sessions held by pharmaceutical |
| pharmaceutical training to advise them on their | | | | consultancy firms and the knowledge that they gain |
| processes and how they comply with the Medical | | | | there will then be communicated back to other |
| Device Directive. The MDD was published by the | | | | employees once back at work. This is often a more |
| European Commission (EC) in June 1993 and describes | | | | cost-effective method of pharmaceutical training on |
| the medical device industry in its member states. | | | | medical devices however if you have a large number |
| Manufacturers who supply or produce devices in the | | | | of staff involved in the process then you may want |
| territory covered by the EC need to keep up to | | | | to consider the first option as you will have training |
| date with any changes that are made to the | | | | coming directly from the experts to your staff |
| directive in the way of appendices and add-ons. | | | | instead of through a chain. |
| These occur when there are major developments in | | | | If your company manufactures medical devices and |
| the industry. They are by no means a regular | | | | you sell your products in territory which falls under |
| occurrence however every time production | | | | the European Commission and the MDD, then you |
| companies come up with a new process or product, | | | | should think about having some pharmaceutical |
| they need to make sure that it meets the standards | | | | training, even if it just as a refresher course. |
| of the European Commission if they want to sell it on | | | | |